lyme disease vaccine - Search News

Pfizer Lyme Disease Vaccine Shows 70% Efficacy

Pfizer Lyme vaccine shows more than 70% efficacy but misses key statistical goal

Pfizer and Valneva said on Monday their Lyme disease vaccine showed more than 70% efficacy in a late-stage study, even as it missed its main goal.

· 8h

A Lyme Disease Vaccine Is Coming, But Experts Warn of a Major Catch in Pfizer’s Research

· 16h

Lyme disease vaccine shows strong results. How it works.

· 2d

Pfizer Lyme Disease Vaccine Shows 70% Efficacy, But Misses Statistical Goal

Pfizer and Valneva said on Monday their Lyme disease vaccine showed more than 70% efficacy in a late-stage study, even as it missed its main goal.

· 20h

Pfizer’s Lyme Vaccine Misses Mark in Study, Complicating Quest for Approval

· 1d

Doctors say Lyme disease vaccine trial results 'encouraging' with 70% efficacy shown

Pfizer to seek FDA approval for Lyme vaccine as CT report shows ticks are more abundant than ever

The annual tick report shows Lone Star ticks have established populations along Connecticut's shoreline, raising the risk of the red-meat allergy caused by alpha-gal syndrome.

Finally, Some Good News in the Fight Against Lyme Disease

Scientists found that the experimental vaccine was more than 70% effective at preventing Lyme disease in a trial of nearly 10,000 volunteers.

sharewise

VALN Stock Nosedives on Mixed Results From Lyme Disease Vaccine Study

Shares of Valneva VALN tanked 37% on Monday after the company reported top-line results from the phase III VALOR study, which evaluated its experimental Lyme disease vaccine, PF-07307405 (formerly